VibeOne: AI due diligence for therapeutics
Find landscapes of assets, triage the assets with the highest potential, and find differentiated programs.
Search & eval made easy
From scanning indications to drug program deep dives, move faster and with confidence. VibeOne uses artificial intelligence and multimodal large language models to make BD efforts more efficient and comprehensive. Get results in days, not months.
Optimize
Allocate time, capital, and resources strategically and efficiently
Identify
Don’t miss any assets. Identify new drugs, indications, and expansion opportunities
Discover
Uncover hidden gems and choose programs with the highest potential to move forward
Succeed
Analyze your drug’s likelihood of success based on current market landscape data
From unstructured documents to decisions—in days
VibeOne helps you move faster and de-risk decisions across the BD funnel. Whether you’re exploring new opportunities or evaluating a shortlist, our expert-guided AI delivers strategic clarity—fast.
VibeOne capabilities
Understand & target the full landscape of potential assets
Approach scientific & clinical assessments with clarity
Track catalysts that impact data and strategic decisions
Triage opportunities & prioritize based on the latest information
“A mission-driven culture, with patient impact as the North Star, is essential, and objectivity is equally important. Be willing to walk away if the data doesn’t support a program.”
Shalini Sharp, experienced board member and former biotech CFO
Accelerate & improve the due diligence process
Too many opportunities. Too little time. VibeOne helps business development and in-licensing teams cut through the noise, identify high potential programs quickly, and deep dive into the assets that truly fit your strategy.
Accelerate time to insight, without biases
Learn how VibeOne boosts your business development or portfolio prioritization projects.